Galectin-4

Galectin-4 is a protein that in humans is encoded by the LGALS4 gene. Galectin-4 is a member of the galectin family, a group of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. This protein plays a significant role in the gastrointestinal tract, where it is predominantly expressed. It is involved in various cellular functions, including apoptosis, cell proliferation, cell differentiation, and cell adhesion, and has been studied for its implications in cancer, particularly colorectal cancer and gastric cancer.

Structure and Function

Galectin-4 is a tandem-repeat type galectin, meaning it possesses two carbohydrate recognition domains (CRDs) connected by a linker peptide. This structure allows galectin-4 to cross-link glycoconjugates, facilitating its role in cell adhesion and signaling. In the gastrointestinal tract, galectin-4 contributes to the formation of the intestinal epithelial barrier, playing a crucial role in maintaining intestinal homeostasis and protecting against pathogen invasion.

Expression and Localization

The expression of galectin-4 is highly specific to the gastrointestinal tract, particularly in the colon and small intestine. Within these tissues, it is localized to the apical surface of enterocytes, where it can interact with glycolipids and glycoproteins of the cell membrane. This specific localization is essential for its function in forming and stabilizing the mucosal barrier.

Role in Disease

Galectin-4 has been implicated in various diseases, primarily due to its role in cell adhesion, proliferation, and apoptosis. In inflammatory bowel disease (IBD), alterations in galectin-4 expression have been observed, suggesting a potential role in the pathogenesis of this condition. Furthermore, its involvement in cancer has been extensively studied, with evidence suggesting that galectin-4 can act as both a tumor suppressor and a promoter, depending on the cellular context and type of cancer. In colorectal and gastric cancers, galectin-4 expression is often altered, and its levels have been associated with tumor progression, metastasis, and patient prognosis.

Clinical Significance

Given its role in cancer and inflammatory diseases, galectin-4 is being explored as a potential biomarker for diagnostic and prognostic purposes. Additionally, targeting galectin-4 through inhibitors or antibodies is being investigated as a therapeutic approach for treating cancers and other diseases where galectin-4 plays a critical role.

Research Directions

Research on galectin-4 continues to uncover its complex roles in health and disease. Future studies aim to elucidate the detailed mechanisms by which galectin-4 contributes to disease pathogenesis and to explore its potential as a target for therapeutic intervention. Understanding the interactions between galectin-4 and other cellular molecules may also reveal new insights into cell biology and disease processes.

Galectin-4
Identifiers
Symbol	?

‎